Fine Foods & Pharmaceuticals N.T.M. S.p.A. (BIT:FF)
Italy · Delayed Price · Currency is EUR 8.54
-0.86 (-9.15%)
May 7, 2026, 5:35 PM CET
BIT:FF Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 252.06 | 243.75 | 251.81 | 206.85 | 194.85 |
Other Revenue | - | - | 0.21 | - | - |
| 252.06 | 243.75 | 252.03 | 206.85 | 194.85 | |
Revenue Growth (YoY) | 3.41% | -3.28% | 21.84% | 6.16% | 10.35% |
Cost of Revenue | 164.26 | 164.23 | 183.47 | 152.91 | 138.96 |
Gross Profit | 87.79 | 79.53 | 68.56 | 53.94 | 55.89 |
Selling, General & Admin | 53.32 | 48.27 | 45.11 | 38.65 | 35.39 |
Other Operating Expenses | 0.76 | 1.67 | 1.29 | 0.35 | 1.09 |
Operating Expenses | 72.1 | 65.71 | 62.53 | 54.45 | 49.88 |
Operating Income | 15.7 | 13.82 | 6.03 | -0.51 | 6.01 |
Interest Expense | -2.89 | -3.3 | -4.81 | -2.03 | -0.69 |
Interest & Investment Income | 0.03 | 0.67 | 0.28 | 0.01 | 0 |
Currency Exchange Gain (Loss) | 0.08 | -0.1 | -0.02 | -0.12 | -0.04 |
Other Non Operating Income (Expenses) | 0.53 | 0.6 | 0.07 | -2.88 | 0.08 |
EBT Excluding Unusual Items | 13.45 | 11.69 | 1.55 | -5.54 | 5.37 |
Impairment of Goodwill | - | - | -4.4 | - | - |
Gain (Loss) on Sale of Investments | - | -0.01 | 1.7 | -7.73 | -8.9 |
Gain (Loss) on Sale of Assets | 0.12 | 0.26 | 0.03 | 0.06 | 0.07 |
Asset Writedown | - | -0 | -0.68 | -0.97 | -1.13 |
Legal Settlements | - | -0.1 | - | - | - |
Other Unusual Items | - | - | -0.17 | -0.02 | -0.01 |
Pretax Income | 13.57 | 11.83 | -1.86 | -14.2 | -4.59 |
Income Tax Expense | 3.47 | 3.68 | 1.67 | -4.7 | -3.16 |
Earnings From Continuing Operations | 10.1 | 8.16 | -3.52 | -9.5 | -1.43 |
Net Income to Company | 10.1 | 8.16 | -3.52 | -9.5 | -1.43 |
Net Income | 10.1 | 8.16 | -3.52 | -9.5 | -1.43 |
Net Income to Common | 10.1 | 8.16 | -3.52 | -9.5 | -1.43 |
Net Income Growth | 23.80% | - | - | - | - |
Shares Outstanding (Basic) | 24 | 24 | 26 | 26 | 24 |
Shares Outstanding (Diluted) | 24 | 24 | 26 | 26 | 24 |
Shares Change (YoY) | -0.57% | -4.21% | - | 6.76% | -2.12% |
EPS (Basic) | 0.41 | 0.33 | -0.14 | -0.37 | -0.06 |
EPS (Diluted) | 0.41 | 0.33 | -0.14 | -0.37 | -0.06 |
EPS Growth | 24.24% | - | - | - | - |
Free Cash Flow | -2.87 | 11.96 | 0.41 | -11.34 | -20.68 |
Free Cash Flow Per Share | -0.12 | 0.49 | 0.02 | -0.44 | -0.86 |
Dividend Per Share | 0.160 | 0.140 | 0.120 | 0.100 | 0.160 |
Dividend Growth | 14.29% | 16.67% | 20.00% | -37.50% | 14.29% |
Gross Margin | 34.83% | 32.63% | 27.20% | 26.08% | 28.68% |
Operating Margin | 6.23% | 5.67% | 2.39% | -0.25% | 3.08% |
Profit Margin | 4.01% | 3.35% | -1.40% | -4.59% | -0.73% |
Free Cash Flow Margin | -1.14% | 4.91% | 0.16% | -5.48% | -10.61% |
EBITDA | 33.22 | 29.13 | 21 | 13.66 | 18.77 |
EBITDA Margin | 13.18% | 11.95% | 8.33% | 6.61% | 9.63% |
D&A For EBITDA | 17.52 | 15.31 | 14.97 | 14.17 | 12.77 |
EBIT | 15.7 | 13.82 | 6.03 | -0.51 | 6.01 |
EBIT Margin | 6.23% | 5.67% | 2.39% | -0.25% | 3.08% |
Effective Tax Rate | 25.59% | 31.07% | - | - | - |
Revenue as Reported | 253.46 | 245.07 | 252.91 | 208.32 | 195.24 |
Advertising Expenses | 0.78 | 0.58 | 0.61 | 0.31 | 0.56 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.